These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effect of cimetidine administration on the pharmacokinetics of pirmenol. Stringer KA; Lebsack ME; Cetnarowski-Cropp AB; Goldfarb AL; Radulovic LL; Bockbrader HN; Chang T; Sedman AJ J Clin Pharmacol; 1992 Jan; 32(1):91-4. PubMed ID: 1740542 [TBL] [Abstract][Full Text] [Related]
9. Preclinical and clinical pharmacokinetics of pirmenol. Chang T Am J Cardiol; 1987 Jun; 59(16):15H-19H. PubMed ID: 2438922 [TBL] [Abstract][Full Text] [Related]
10. Effect of pirmenol on premature atrial complexes. Toivonen LK Ann Clin Res; 1986; 18(2):106-8. PubMed ID: 3521442 [TBL] [Abstract][Full Text] [Related]
11. Preclinical toxicology of pirmenol hydrochloride. Martin RA; de la Iglesia FA Am J Cardiol; 1987 Jun; 59(16):10H-14H. PubMed ID: 3591709 [TBL] [Abstract][Full Text] [Related]
13. Lack of effect of tacrine administration on the anticoagulant activity of warfarin. Reece PA; Garnett WR; Rock WL; Taylor JR; Underwood B; Sedman AJ; Rajagopalan R J Clin Pharmacol; 1995 May; 35(5):526-8. PubMed ID: 7657855 [TBL] [Abstract][Full Text] [Related]
14. Acute haemodynamic effects of the antiarrhythmic agent pirmenol in cardiac patients: a comparison with lidocaine. Nieminen MS; Toivonen LK; Manninen V; Frick MH Eur Heart J; 1986 Feb; 7(2):150-7. PubMed ID: 3516703 [TBL] [Abstract][Full Text] [Related]
15. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide. Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418 [TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of oral pirmenol in suppressing ventricular premature depolarizations. de Buitleir M; Crevey BJ; Johnson T; Kou WH; Nelson SD; Schmaltz S; Morady F Am Heart J; 1988 Aug; 116(2 Pt 1):379-84. PubMed ID: 2456681 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in mice. Sato K; Taniuchi Y; Kawasaki T; Hirayama F; Koshio H; Matsumoto Y; Iizumi Y Jpn J Pharmacol; 1998 Oct; 78(2):191-7. PubMed ID: 9829622 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of pirmenol in young and elderly subjects. Ferry DG; Campbell AJ; Bland R; Beasley M; Gazeley L; Edwards IR Eur J Clin Pharmacol; 1992; 43(4):437-9. PubMed ID: 1451728 [TBL] [Abstract][Full Text] [Related]
19. Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study. Anderson JL; Lutz JR; Nappi JM Am J Cardiol; 1984 Feb; 53(4):522-7. PubMed ID: 6198894 [TBL] [Abstract][Full Text] [Related]